Diagnostic companies shift attention to multiplex tests for COVID-19, flu

by on

Several companies have launched, or plan to launch, multiplex molecular tests to help providers determine which virus a patient may have and then treat them appropriately.

Several companies have launched, or plan to launch, multiplex molecular tests to help providers determine which virus a patient may have and then treat them appropriately.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: